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Pain in cancer is a common and burdensome symptom with diﬀerent causes but in a signiﬁcant number of cases it is undiagnosed
and undertreated because of lack of skills for its assessment. Pain has signiﬁcant negative impact on the patient and, therefore,
it needs to be managed urgently and appropriately. In resource-limited settings, there are several barriers and challenges to pain
management but even in these circumstances pain can be well managed with planned and innovative use of resources and if the
World Health Organization public health system approach is used to ensure opioid availability.
1.Introduction
Pain in cancer patients is one of the most feared and
burdensome symptoms [1] and is often undertreated [2].
In a recent systematic review, the prevalence of pain was
found to be 64% in patients with advanced and metastatic
disease, 59% in those on anticancer treatment, and 33%
in those who had been cured of cancer [1]. In Africa, the
prevalence of cancer pain ranges from 35.7% to 87.5% with
the prevalence being more than 70% in most of the studies
[3–9]. This high prevalence may be attributed to the limited
treatment options for cancer, individuals presenting late,
and comorbidity along with limited choice and availability
of analgesics. In developed countries, evidence shows that
56–85% of cases of pain in cancer are tumor related, 5–
62% of cases are related to cancer treatment, and 3–22%
are unrelated to the cancer or its treatment [10, 11]. There
is limited published data from resource-limited settings on
the causes of pain in cancer patients; most data is limited
to prevalence of pain in these patients and in most cases
it is assumed that pain is due to the tumor [3–9, 12, 13].
This is probably because in resource-limited countries there
are limited treatment options for most cancers, and patients
present late with advanced malignancy, and, therefore, it is
likely that more of the pain will be due to the tumor and
less due to treatment as compared to developed countries.
Pain unrelated to the cancer or its treatment is of signiﬁcant
importance in resource-limited settings, where the burden
of HIV/AIDS is high and, therefore, patients might have
HIV-associated malignancies and their pain may be due
to the HIV or associated opportunistic infections and/or
antiretroviral treatment.
Therefore, a good pain assessment is important to iden-
tify the cause and be able to manage it eﬀectively.
2. The Impactof Cancer Painon the Patient
Chronic cancer pain has a signiﬁcant impact on the patients
and their family. Thirty-six percent of patients on anticancer
treatment have reported their pain to be of moderate-to-
severeintensityand45%ofpatientswithadvanced,terminal,
and metastatic disease reported pain of moderate-to-severe
intensity in a systematic review done on studies carried
out mainly in developed countries [1]. In resource-limited
settings, pain has been found to be of moderate-to-severe
intensity in 30% to 70% of cases. In the majority of the
studies, moderate-to-severe pain was registered in more than
50% of the patients [3, 13–16].
An individual’s perception of pain may be inﬂuenced
by many issues including psychological, social, cultural,
and spiritual factors. Koﬀman et al. explored the cultural2 Pain Research and Treatment
meanings of pain in White British and Black Caribbean.
TheyfoundthattheBlackCaribbeanhadahigherprevalence
of pain and reported more refractory pain than the White
British. Speciﬁc to the Black Caribbean population in this
study was the belief that pain was a test of faith and a pun-
ishment. Therefore, patients may be able to accommodate
distress depending on what meaning is held about the pain
[17]. In some cultures in Africa, it has been observed that
children and adults will not complain of pain or express it
because it is a cultural norm not to appear weak and to show
consideration for family members and health professionals
[18,19].Intheauthors’experience,mostadultsinAfricawill
denyorunderreporttheirpainsothattheydonotdiscourage
their health care and nonhealth care carers. Also they will
underreport pain because it is expected of them from the
society to bear some pain. This may be one of the factors
contributingtothelowerdosagesofopioidsusedasobserved
in Uganda.
Unrelieved pain is associated with unnecessary suﬀering,
functional impairment, aﬀects sleep and appetite, leads to
psychologicalandspiritualdistress,andmayleadtorejection
of a potentially beneﬁcial treatment modality if it leads to
pain which may impact one’s survival [20, 21]. Severe pain
that aﬀects one’s performance of activities of daily living and
enjoyment of life, has been found to be a predictor of anxiety
and depression [22].
3. Pain Assessment and Management
Pain assessment is a prerequisite for the diagnosis and
appropriate management of pain. However, deﬁciencies
in pain assessment and management have been found in
several settings where cancer patients are seen [23]. In
manyresource-limitedsettings,therearefewoncologistsand
palliative care specialists and many cancer patients may be
treated by Health Professionals without the skills of pain
assessment because there was no provision for palliative
care in their training. Some health professionals pay more
attention to the disease thinking that disease control alone
will lead to pain relief [12]. Assessment of pain is an ongoing
process, which starts with a comprehensive evaluation of
the patient’s pain, symptoms, functional status, and clinical
history, dependent upon the patient’s presenting needs.
When assessing an individual’s pain, it is important to not
manage the pain in isolation and to treat the underlying
cause where possible [24].
4. Management of Cancer Pain
The control of pain and suﬀering is central to health, and
the right to health is stipulated in several International
declarations [25]. The Korean declaration states that “Every
individual has the right to pain relief” [26] .T h eC a p eT o w n
Declaration in 2002 stated that the control of pain and
symptoms is a human right, and, therefore, appropriate
drugs should be available in every country in sub-Saharan
Africaaspartoftheessentialdruglist,includingopioidssuch
as morphine. These drugs should be available and accessible
at all levels including the community [27]; however, this is
oftennotthecase[28].Thehumanrightsinitiativeadvocates
forpainreliefasahumanrightandthedenialofpainreliefor
thenonaccessibility ofpalliativecareasanabuseofthisright.
[29]In70–90%ofpeoplewithcancerpain,theWorldHealth
Organization (WHO) approach to pain management which
emphasizes the principles of “by the clock, by the mouth, by
theladder,andbytheindividual”issuﬃcientforpaincontrol
[30].
The analgesic ladder (Figure 1) is a stepwise approach to
the management of pain based on the severity and the type
of pain [30].
Mild pain is treated using nonopioids such as paraceta-
mol and nonsteroidal anti-inﬂammatory drugs (NSAIDS-
Step-1); if mild pain is not controlled or if the pain is more
severe, opioids for mild-to-moderate pain should be used in
addition to the NSAIDs (Step 2). Severe or moderate pain,
or pain not controlled by Step2 analgesics, is treated with
strong opioids (Step 3), see Figure 1. Adjuvant analgesics
should also be used at any of the steps if appropriate, for
example, for bone pain, nerve pain, or pain not fully relieved
by opioids, and laxatives should be given for patients on
opioids to prevent constipation and other side eﬀects should
be managed. This 3-step ladder is currently being challenged
as in some parts of the world, for example, Africa, step 2
medications are expensive and practice has developed that
uses low-dose oral morphine (Step 3) for moderate pain.
This may prove to be an eﬀective and eﬃcient model and
is an ongoing subject for research. The 2-step ladder is being
recommended in the new guidelines for the management of
persistent pain in children, along with a call for research in
this area [31].
Despite the success of the WHO analgesic ladder, much
cancer pain remains uncontrolled. The prevalence of under-
treatment of pain has been found to be as much as 43%
[32]. There are many barriers to eﬀective pain control, and
these include a lack of national policies and low priority
assigned to pain relief; a lack of national standards and
guidelines for providing pain control medications; legal
restrictions on the importation and medical use of opioids;
the greatly exaggerated concern that the use of opioids will
lead to drug abuse and addiction; lack of awareness by health
professionals and the public including families who care
for the dying at home that cancer pain can be relieved;
social stigma surrounding cancer which delays or prevents
adequate treatment of the disease and pain [33].
The low priority assigned to pain relief is reﬂected
in the few palliative care services that are available in
many resource-limited countries. For example, India with a
populationof1.2billion,hasjustafewlocalizedserviceswith
the exception of the state of Kerala [34].
Areas of longstanding conﬂict, political instability, or
natural disaster face the biggest challenges for health care in
general, and palliative care in particular. Drug availability is
also a major challenge for pain control in resource-limited
settings. Opioids are key in the management of severe pain,
and morphine consumption is a proxy measure of the degree
of pain control. Morphine and codeine are both considered
to be essential drugs and appear on the WHO essential drugsPain Research and Treatment 3
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Figure 1: WHO analgesic ladder.
list. Essential drugs are deﬁned as those that satisfy the health
care needs of the majority of the population, that should be
availableallthetimeinadequateamountsandinappropriate
dosages [35]. However, despite this, opioid availability is
very limited in many resource-limited countries. In 2007,
seven developed countries accounted for more than 80% of
global morphine consumption, while developing countries
which represent more than 80% of the world’s population
accounted for less than 10% [36]. In India, it is estimated
that less than 0.4% of the 1.2 billion population has access to
oral morphine [34].
In a survey done in 12 African countries looking at
the availability of pain-relieving medications, factors that
aﬀected opioid availability included (Table 1) issues related
to policy, clinical issues, and resource issues [35].
Thus the provision of pain control forpeople with cancer
in low resource settings poses a challenge for all involved.
5. StrategiesThat HaveBeen Used in
Resource-LimitedSettingsto
Improve Pain Control
A public health systems approach as recommended by
the WHO is essential in addressing issues of availability
and access to opioids and ultimately pain control. In
this approach, there are four key foundation measures in
ensuring sustainable palliative care services. These include a
government policy, drug availability, education, and imple-
mentation (Figure 2)[ 37].
Table 1: Factors aﬀecting opioid availability in 12 African coun-
tries.
Policy issues Clinical issues Resources
-Tight regulations on
opioids
-No national policy
-Bureaucratic process
for legislation
-Punitive regulations
-Inadequate ability to
report consumption
to the narcotics board
-Lack of political will
-Limited time for
prescription
-Lack of knowledge
and skills by health
professionals to assess
and manage pain
-Fear of addiction
-Lack of enough
prescribers
-Unreliable stocks
-Few dispensers
-Lack of storage
for opioids
5.1. Policy. The WHO recommends that all governments
evaluate their policies and procedures to ensure that while
opioids are controlled to prevent drug abuse and drug
traﬃcking they are received by patients requiring analgesia
[38]. Established in 1996, the Pain and Policy Studies Group
(PPSG) has played an important role in evaluating national
reports and policies and has worked in collaboration with
palliative care professionals and governments in many parts
of the developing world. It examines trends, identiﬁes barri-
ers, and seeks to develop plans to improve the availability of
opioids [39].
In some resource-limited countries, such as Uganda,
addressing the foundation measures has been crucial in de-
velopingsustainablepalliativecareservicesandhasenhanced
pain control. In Uganda, there was extensive advocacy to
health oﬃcials, health planners, health care professionals,
pharmacists, political leaders, and the community for several
years. Following this a stakeholder’s workshop was convened
in 1998 and a task force established to draft a national
policy for palliative care. The Ministry of Health at the
same time was discussing the ﬁrst Health Service Strategic
Plan (HSSP) for the years 2000–2005. Through further
advocacy and WHO support, the Palliative Care Policy was
incorporated into the HSSP, and palliative care was put
in the package of essential clinical services to be delivered
in government health institutions, for the ﬁrst time [40].
The policy provides for the provision of palliative care
drugs including pain medication, capacity building for
palliative care, strengthening referral systems for palliative
between health services and home care, and community-
based rehabilitation of the terminally ill [40].
In India, PPSG worked in partnership with the Indian
palliative care workers and the central and state governments
to bring about reforms in the policies including exempting
all palliative care centres from the need for a drug licence,
which freed palliative care centres from the need to have
a pharmacist. The government of India in 1998 instructed
all state governments to amend and simplify their narcotics
regulations [39]. The Government of India has also included
palliative care in the National Cancer Control Programme 5-
year plan which began in April 2007. However, changes in
policyalo neha v enotbee ns uﬃcientto improve opioid avail-
ability in this country. The experience in India, therefore,4 Pain Research and Treatment
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stresses the need for a comprehensive public health approach
for palliative care [34].
5.2. Drug Availability. To ensure drug availability, it is not
enoughjusttoaddresspolicybarriers,thereshouldalsobean
eﬀective distribution network and there is a need to remove
other barriers such as a poor distribution system and lack of
trained personnel which leads to lack of accessibility. Poorly
developed health systems are, therefore, a signiﬁcant limiting
factor with the growth of palliative care linked to indices of
human development and economic strength [41].
Lackofhealthcareworkersabletodispenseandprescribe
is a major issue in Africa as prescribing is limited to those
with special licenses or training (commonly doctors), and
yet there are very high patient-to-doctor ratios [41]. An
innovative approach was taken to this obstacle in Uganda
by an amendment to the existing narcotics legislation to
allow specialist palliative care nurses and clinical oﬃcers to
prescribe morphine [42]. Uganda was the ﬁrst country to
makethisimportantstep.Currently,thesenursesandclinical
oﬃcers complete a nine-month, full-time, Clinical Palliative
CareCourse(CPPC)orabachelor’sdegreeinPalliativeCare,
and both of these programs include theoretical learning,
practical skills training in a number of clinical settings,
and exposure to a public health planning approach. These
graduatesthenareabletoprescribemorphineinthediﬀerent
districts in Uganda. This highly successful model is being
closely watched by several other countries, and an evaluation
of the programme is planned; however, it may oﬀer a major
advance in morphine accessibility [41].
5.3. Education. Education in palliative care is paramount in
ensuring a change in culture, especially to address the barrier
of health professionals’ lack of knowledge and skills for pain
management and to enhance the right attitudes to palliative
care practices. Although regulatory barriers and availability
issues may be addressed, there may be little use of opioids
because of health professionals’ associated barriers [34, 43].
One of the strategies used in Uganda to ensure education
in palliative care was to introduce it in the medical students
and nurses curriculum in 1993 and recently in the curricu-
lum of some of the postgraduate courses. In addition to
the CPCC course that allows nurses to prescribe morphine,
there is a diploma and degree course in palliative care oﬀered
in Uganda for all Africa. There are also short courses for
health professionals, allied health professionals, community
volunteers, and traditional healers.
5.4. Implementation. In implementation, it is important to
identify opinion leaders in the community and in health
care organizations that have potential of becoming centers
of excellence in palliative care based on their leadership
potential then develop a plan to support the evolving
program with the goal of providing care for all [37]. In
Uganda, involving the Deans of medical schools, tutors
in nursing schools, and hospital administrators has been
key in ensuring that palliative care was introduced in the
doctors and nurses’ curricula and in the cases of those who
have already qualiﬁed and are working, to ensure training
in a health professionals’ course in palliative care. After
their training, all the diﬀerent trained health professionals
go to diﬀerent parts of the country and with these skills
are able to manage pain with a wide coverage [40]. The
neighborhood Network in Palliative care Initiative in Kerala
India demonstrates successful community involvement in
palliative care [44].
In resource-limited settings, it is not always possible
to use the WHO 3-step ladder approach to pain control
because of the limited availability of opioids for mild-to-
moderate pain (Step2). These are not usually available
in the government institutions and are expensive on the
openmarket.Morphinepowderreconstitutedintomorphine
solution has been found to be cheaper than step 2 opioids
and, therefore, in Uganda, for example, step 2 analgesia
is provided by giving lower doses of morphine which are
equivalent to step 2 analgesia. There is also a challenge in
giving analgesia on the clock when some of the population in
theruralareashavenoclocks.Somepalliativecareservicesin
Uganda have designed a treatment card guiding patients on
when to take their drugs using the sun rising and setting.
Getting the appropriate dosage for those who live very
far from the health care services and will not be reviewed
in a short time is also another challenge. In India, research
has shown that the daily oral morphine requirement can be
determined by giving small boluses of 1.5mg of intravenous
morphine at short intervals of about every 10 minutes until
pain is controlled or until the patient becomes drowsy and
the oral four-hour dose needed was found to be equal to the
total initial intravenous requirement [45].
Another challenge is the patient who is dying or is
unconscious and is in pain, given the limited facilities or lack
of, thereof, subcutaneous use of opioids. In Uganda, higher
concentrations of morphine in small amounts of liquid are
given to be absorbed buccally, and in India, families have
been taught to use the subcutaneous morphine at home.
Pain unresponsive to the analgesic ladder is a challenge
in resource-limited settings where anesthetic techniques
may be out of reach because of the limited number of
anesthetists and because they are expensive. The use of the
intravenous formulation of ketamine orally for control of
pain unresponsive to the WHO analgesic ladder has been
studied in small studies in several settings [46]. KetaminePain Research and Treatment 5
is cheap and readily available and is worth considering for
resource-limited countries.
6. Conclusion
Cancer pain of moderate-to-severe intensity is common in
resource-limited settingsand impactsthesuﬀerers’quality of
life.Painreliefisahumanrightwhichshouldbeobservedfor
everyone. There are several challenges in pain management
in resource poor settings but these can be overcome through
the adoption of the WHO public health systems approach
to integrating palliative care services. This involves having
a government policy on pain management and ensuring
opioid availability and accessibility. It also means educating
health care professionals on pain assessment and manage-
ment as well as mobilizing and empowering the public
on the need to control pain. Given the limited resources
and overwhelming need, local champions have a crucial
role in developing and implementing innovative solutions
underpinned by a rich evidence base. Quality of care needs
to be considered alongside increasing coverage. Crucial to
thisapproachwillbeintegrationtostrengthenhealthsystems
and ensuring pain control becomes embedded in models of
delivery of health care. There is a need for being innovative
and maximizing use of available use of resources in pain
management in these settings.
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